Add subject to electronic mail alerts Obtain an electronic mail when new articles are posted…
Read More
FDA approves Dupixent for persistent spontaneous urticaria
The U.S. Meals and Drug Administration has authorized Dupixent (dupilumab) for the therapy of adults and adolescents with persistent spontaneous…
Read More
